Natural Capsules Ltd. | Small-cap | Healthcare
₹206.42
9.06%
| Natural Capsules Stock Comparison:
Natural Capsules vs Sun PharmaceuticalNatural Capsules vs Divi's LaboratoriesNatural Capsules vs Innova CaptabNatural Capsules vs Sequent ScientificNatural Capsules vs Sun Pharma AdvancedNatural Capsules vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 452.0M
Gross Profit 216.3M 47.85%
Operating Income -38.9M -8.61%
Net Income -55.8M -12.35%
EPS (Diluted) ₹-5.40

Balance Sheet Metrics

Total Assets 4.2B
Total Liabilities 1.6B
Shareholders Equity 2.6B
Debt to Equity 0.63

Cash Flow Metrics

Revenue & Profitability Trend

Natural Capsules Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.6B1.5B1.6B1.3B740.2M
Cost of Goods Sold i884.3M823.6M819.1M614.9M377.6M
Gross Profit i757.3M689.3M828.1M683.8M362.6M
Gross Margin % i46.1%45.6%50.3%52.7%49.0%
Operating Expenses
Research & Development i16.0M20.8M23.9M21.2M9.8M
Selling, General & Administrative i158.3M107.9M129.9M101.6M64.5M
Other Operating Expenses i243.0M230.0M244.5M197.4M112.4M
Total Operating Expenses i417.3M358.7M398.3M320.2M186.7M
Operating Income i90.3M103.2M272.4M229.7M77.3M
Operating Margin % i5.5%6.8%16.5%17.7%10.4%
Non-Operating Items
Interest Income i1.5M9.2M3.7M2.1M1.4M
Interest Expense i63.1M51.3M34.1M19.6M3.7M
Other Non-Operating Income-----
Pre-tax Income i27.9M80.5M249.9M193.9M91.6M
Income Tax i21.7M25.0M65.5M54.7M22.4M
Effective Tax Rate % i77.9%31.0%26.2%28.2%24.5%
Net Income i6.2M55.5M184.5M139.1M69.1M
Net Margin % i0.4%3.7%11.2%10.7%9.3%
Key Metrics
EBITDA i187.4M219.1M356.9M290.4M122.1M
EPS (Basic) i₹0.63₹6.25₹19.86₹19.84₹11.09
EPS (Diluted) i₹0.63₹6.25₹19.86₹19.84₹11.09
Basic Shares Outstanding i98360009304000927600070120006233000
Diluted Shares Outstanding i98360009304000927600070120006233000

Income Statement Trend

Natural Capsules Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i6.6M19.5M12.7M14.0M975.0K
Short-term Investments i45.4M110.1M52.8M33.5M4.5M
Accounts Receivable i622.4M544.7M521.3M263.0M267.0M
Inventory i254.6M190.4M88.5M45.8M66.1M
Other Current Assets6.6M4.9M3.7M38.0M5.6M
Total Current Assets i1.3B1.2B1.0B755.8M496.9M
Non-Current Assets
Property, Plant & Equipment i31.2M15.8M15.8M15.8M10.9M
Goodwill i-1.0K4.8M11.1M17.4M0
Intangible Assets i-1.0K4.8M11.1M17.4M-
Long-term Investments-----
Other Non-Current Assets1.0K-1.0K1.0K1.0K1.0K
Total Non-Current Assets i2.9B2.5B1.9B886.9M473.5M
Total Assets i4.2B3.8B2.9B1.6B970.4M
Liabilities
Current Liabilities
Accounts Payable i385.1M304.2M274.3M159.8M160.8M
Short-term Debt i477.7M410.6M261.5M180.2M98.2M
Current Portion of Long-term Debt-----
Other Current Liabilities39.4M19.4M24.6M22.5M14.9M
Total Current Liabilities i999.9M764.7M669.4M447.7M333.9M
Non-Current Liabilities
Long-term Debt i574.3M679.5M706.5M347.6M4.7M
Deferred Tax Liabilities i42.5M33.0M27.7M16.8M9.6M
Other Non-Current Liabilities-2.0K-1.0K-1.0K50.0K
Total Non-Current Liabilities i622.0M712.5M735.7M365.3M15.5M
Total Liabilities i1.6B1.5B1.4B813.0M349.4M
Equity
Common Stock i103.4M93.3M92.8M70.1M62.3M
Retained Earnings i794.9M781.0M734.6M557.8M426.9M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i2.6B2.3B1.5B829.8M621.0M
Key Metrics
Total Debt i1.1B1.1B967.9M527.8M102.9M
Working Capital i295.9M472.9M345.6M308.2M163.0M

Balance Sheet Composition

Natural Capsules Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i27.9M80.5M249.9M193.9M91.9M
Depreciation & Amortization i-----
Stock-Based Compensation i2.9M1.1M0--
Working Capital Changes i11.3M-301.1M-247.0M-218.2M-135.1M
Operating Cash Flow i103.9M-177.4M33.3M-11.2M-42.2M
Investing Activities
Capital Expenditures i-446.3M-714.1M-1.1B-443.0M-164.1M
Acquisitions i-----
Investment Purchases i0-27.3M0-372.0K0
Investment Sales i00372.0K077.4M
Investing Cash Flow i-446.3M-741.4M-1.1B-443.4M-86.7M
Financing Activities
Share Repurchases i-----
Dividends Paid i--9.3M-7.7M-6.2M-3.7M
Debt Issuance i-124.6M442.7M426.4M33.7M
Debt Repayment i-51.9M0000
Financing Cash Flow i226.5M870.9M911.5M498.0M63.6M
Free Cash Flow i-178.8M-799.8M-886.7M-466.0M-106.3M
Net Change in Cash i-116.0M-47.9M-111.6M43.4M-65.3M

Cash Flow Trend

Natural Capsules Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 337.98
Price to Book 0.84
Price to Sales 1.14
PEG Ratio -0.36

Profitability Ratios

Profit Margin -3.18%
Operating Margin -8.61%
Return on Equity 0.24%
Return on Assets 0.15%

Financial Health

Current Ratio 1.30
Debt to Equity 40.91
Beta -0.26

Per Share Data

EPS (TTM) ₹-5.42
Book Value per Share ₹225.25
Revenue per Share ₹173.50

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
natcapsuq2.0B337.980.840.24%-3.18%40.91
Sun Pharmaceutical 3.9T37.285.3715.08%19.29%3.26
Divi's Laboratories 1.6T69.8010.7414.64%23.89%0.03
Innova Captab 49.4B37.875.1213.37%9.98%35.24
Sequent Scientific 46.9B157.766.442.84%1.85%62.47
Sun Pharma Advanced 46.7B-13.68-21.57157.88%-53.22%-1.24

Financial data is updated regularly. All figures are in the company's reporting currency.